Characteristics and Outcomes of Patients with Systemic Lupus Erythematosus-associated Thrombotic Microangiopathy, and Their Acquired ADAMTS13 Inhibitor Profiles.

CONCLUSION: Acquired ADAMTS13 deficiency is associated with more severe thrombocytopenia and CNS involvement, mild renal involvement, rapid resolution, and relatively good treatment response in SLE-associated TMA. PMID: 30008460 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30008460?dopt=Abstract

Source: J Rheumatol - July 15, 2018 Category: Rheumatology Authors: Yue C, Su J, Gao R, Wen Y, Li C, Chen G, Zhang X, Li X Tags: J Rheumatol Source Type: research

More News: Lupus | Proteinuria | Rheumatology | Thrombocytopenia